Abiopharma

New Form SCHEDULE 13G - DraftKings Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000198 <b>Size:</b> 8 KB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023673 <b>Size:</b> 1 MB

(30% Negative) PDS BIOTECHNOLOGY CORP (PDSB) Reports Q3 2026 Financial Results

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023671 <b>Size:</b> 1 MB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039785 <b>Size:</b> 998 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039784 <b>Size:</b> 611 KB

New Form SCHEDULE 13G - Gesher Acquisition Corp. II <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000197 <b>Size:</b> 10 KB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023669 <b>Size:</b> 1 MB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023667 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - Acrivon Therapeutics, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001875620-26-000015 <b>Size:</b> 17 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039783 <b>Size:</b> 1 MB

(30% Negative) OVID THERAPEUTICS INC. (OVID) Reports Q3 2026 Financial Results

(10% Negative) FATE THERAPEUTICS INC (FATE) Reports Q3 2026 Financial Results

Ovid Therapeutics Inc. - Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Response to SGX Queries: